| Document |
Document Title |
|
WO/2023/162810A1 |
The purpose of the present invention is to provide a method for producing a catalyst compact which has a high mechanical strength and with which it is possible to produce an unsaturated aldehyde and/or an unsaturated carboxylic acid in g...
|
|
WO/2023/162794A1 |
The purpose of the present invention is to provide: a method that can stably produce a catalyst molded article having a high α,β-unsaturated carboxylic acid yield and having an excellent moldability in a step for molding a catalyst dri...
|
|
WO/2023/161095A1 |
The invention relates to the extraction of acrylic acid from aqueous streams. The aim of the invention is to provide a process for extracting acrylic acid from aqueous streams with a low energy expenditure and allowing longer operating t...
|
|
WO/2023/157870A1 |
The purpose of the present invention is to provide: a method for producing methacrolein and/or methacrylic acid from isobutanol, the method suppressing the generation of by-products and realizing highly selective production of methacrole...
|
|
WO/2023/150706A1 |
Provided herein are solid forms of 1-((S)-4-((R)-7-(6-amino-4-methyl-3- (trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((S)-1-m
ethylpyrrolidin-2- yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop-2-en
-1-one and methods of th...
|
|
WO/2023/147665A1 |
The present disclosure relates to compositions for improving gut health and/or milk production in ruminants, comprising: at least one organic acid chosen from sorbic acid, fumaric acid, malic acid, lactic acid, citric acid, formic acid, ...
|
|
WO/2023/143974A1 |
The present invention relates to a process for storing and/or transporting an ethylenically unsaturated compound, the ethylenically unsaturated compound being protected with a phenol against undesired radical polymerization.
|
|
WO/2023/143939A1 |
The present invention relates to a method for storing and/or transporting an ethylenically unsaturated compound, wherein the ethylenically unsaturated compound is protected against undesired radical polymerization with a sterically hinde...
|
|
WO/2023/145605A1 |
The main purpose of the present invention is to provide a catalyst that makes it possible to produce anα,β-unsaturated aldehyde and/or an α,β-unsaturated carboxylic acid with high selectivity. The catalyst is used in producing, via a...
|
|
WO/2023/135304A1 |
A method for fractionating a crude composition comprising at least six fatty acids having each a different chain length into at least four fractions, comprises the following steps: i) feeding the crude composition into a first distillati...
|
|
WO/2023/114926A1 |
Catalysts and catalytic processes for the synthesis of acrylic acid and other a,b-unsaturated carboxylic acids and their salts, which are carried out in a diluent or in the absence of a diluent. In an aspect, ethylene and CO2 can be cont...
|
|
WO/2023/104616A1 |
The invention relates to a novel method for producing isoxazolinecarboxylic acid derivatives of formula (I).
|
|
WO/2023/107345A1 |
A composition and method for dissolving foulant formed in a monomer manufacturing process. The composition may include an amide-containing compound and a solvent. Other components may optionally be included in the composition, such as a ...
|
|
WO/2023/092115A1 |
This disclosure relates to a novel material based on potassium phosphate salt or cesium phosphate salt and silica, comprising at least one source of silica formed into shape with at least one powder of a potassium phosphate or cesium pho...
|
|
WO/2023/081779A1 |
Provided are crystals comprising trans sodium crocetinate, compositions comprising the same, and methods of making and using such crystals. Further, the crystalline compound exhibits an XRPD pattern comprising 2-theta (°) values 4.2, 8....
|
|
WO/2023/072671A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N- oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b...
|
|
WO/2023/072672A1 |
The present invention relates to the use of strobilurin type compounds of formula (I) and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome ...
|
|
WO/2023/072908A1 |
The present invention relates to new co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the class of phenylpropionic or phenylacetic acid derivatives, Lysine and Gabapentin, to their pharmaceutical compositions an...
|
|
WO/2023/061437A1 |
The present invention relates to a salt of an antitumor drug and a crystal form thereof, and specifically relates to a pharmaceutical salt of the compound N-(3-(2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-
7-oxo-6-phenyl-8(7H)-...
|
|
WO/2023/063525A1 |
The present invention relates to a method for preparing acrylic acid, and provides a method for preparing acrylic acid comprising the steps of: supplying an aqueous solution of lactic acid to a reactor and causing a dehydration reaction ...
|
|
WO/2023/063349A1 |
The present invention relates to a catalyst for the production of an unsaturated carboxylic acid, wherein: a catalytically active component represented by formula (1) is contained; the median diameter D50S (mm) of the catalyst is 5.0 mm ...
|
|
WO/2023/063526A1 |
The present invention relates to a method for preparing acrylic acid, the method comprising the steps of: dehydrating, by a reaction section, an aqueous lactic acid solution to prepare a reaction product stream; sequentially passing the ...
|
|
WO/2023/063549A1 |
The present invention relates to a method for preparing an acrylic acid, and provides a method for preparing a high-purity acrylic acid by removing, from a reaction product stream prepared by a dehydration reaction of an aqueous lactic a...
|
|
WO/2023/059681A1 |
A process for producing methacrylic acid comprising: a) producing methacrolein from propionaldehyde and formaldehyde; b) producing methacrylic acid in an oxidative reaction from the methacrolein produced in step a) and water. Step b) is ...
|
|
WO/2023/045985A1 |
Disclosed are a long-chain compound and the use thereof. The structure of the long-chain compound is as shown in formula (I). The compound can directly inhibit ACLY, has a significant therapeutic effect on metabolic diseases represented ...
|
|
WO/2023/045986A1 |
A long-chain compound, a preparation method therefor and the use thereof are disclosed. The structure of said compound is represented by formula (I). The definition of each substituent in the formula is as set out in the description and ...
|
|
WO/2023/048284A1 |
The present invention relates to a method for supporting the operation of a multi-tube reactor or supporting actions to prepare the same, the multi-tube reactor including a plurality of reaction tubes for producing an unsaturated aldehyd...
|
|
WO/2023/041215A1 |
The present invention relates to a vanadium and phosphorus mixed oxide (VPO) catalyst for the partial oxidation of n-butane to maleic anhydride, comprising vanadyl pyrophosphate as main component and at least one first promoter element s...
|
|
WO/2023/038093A1 |
Provided is a deuterium-enriched composition comprising a deuterium-substituted carboxylic acid or a salt thereof, wherein the carboxylic acid or the salt thereof includes an α hydrogen of a carboxy group and a hydrogen other than the Î...
|
|
WO/2023/010213A1 |
The present invention provides anti-fungal compositions comprising at least one unsaturated fatty acid or a pharmaceutically acceptable salt thereof; at least one alpha-hydroxy acid or a pharmaceutically acceptable salt thereof; and at l...
|
|
WO/2023/006503A1 |
The invention relates to a process for preparing acrylic acid, in which process: a product gas mixture containing acrylic acid, water vapour and minor components is produced by means of heterogeneously catalysed gas-phase partial-oxidati...
|
|
WO/2023/001905A1 |
The present invention refers to a compound having the formula (I): R1–Z–C≡C–C≡C–R3 (I) and pharmaceutical compositions comprising the same that can be used in prevention, treatment and alleviation of a fungal infection. The i...
|
|
WO/2023/285509A1 |
The present invention relates to a process for the preparation of a compound having formula (I) wherein R is selected from the group consisting of: halogen, (C1-C6)alkoxy, (C1-C6)alkyl, halo(C1-C6)alkyl, and halo(C1-C6)alkoxy, said proce...
|
|
WO/2023/279995A1 |
A class of anti-bladder-cancer quaternary ammonium salt compounds and the use thereof. The quaternary ammonium salt compound is as shown in formula (I), wherein the definition of each substituent group is detailed in the description. Pro...
|
|
WO/2023/281088A2 |
The present invention relates to a biological method for obtaining an MO monomer comprising an ethylenic unsaturation by bioconversion of a CN compound comprising at least one nitrile function, said CN compound being at least partially r...
|
|
WO/2023/279033A1 |
Provided are novel methods of treatment of conditions such as peripheral tissue oxygenation, interstitial lung disease, dyspnea, ischemia from surgery, brain and pancreatic cancer with increased oxygen diffusivity comprising administerin...
|
|
WO/2022/271846A1 |
Various salt and polymorph forms of Compound (I) represented by the following structural formula, and their corresponding pharmaceutical compositions, are disclosed. Particular crystalline forms of 1:0.5 Compound (I) Semi-Succinate, 1:0....
|
|
WO/2022/263576A1 |
Cocrystal of formula APX∙Bx wherein APX is apixaban (1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)
-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
), B is a pharmaceutically acceptable carboxylic acid selecte...
|
|
WO/2022/257025A1 |
The present application discloses a monatomically dispersed palladium-based catalyst, a preparation method therefor and an application thereof. The monatomically dispersed palladium-based catalyst comprises a main catalytic active compon...
|
|
WO/2022/255368A1 |
The purpose of the present invention is to provide a catalyst capable of producing, with high selectivity, an unsaturated carboxylic acid and/or an unsaturated carboxylic acid ester represented by methyl methacrylate. Provided is a catal...
|
|
WO/2022/255373A1 |
The present invention provides a method for stably obtaining a product. The present invention relates to a tank used in a refining device, characterized in that: the tank is a crystallization tank for generating a slurry that contains cr...
|
|
WO/2022/255371A1 |
The present invention provides a method for efficiently obtaining a high quality product. A method for producing an easily polymerizable compound according to the present invention is characterized by comprising: a step for mixing an eas...
|
|
WO/2022/255372A1 |
The present invention provides a method for stably obtaining a product. The present invention provides a purification apparatus for compounds which comprises a tank used in the purification apparatus and a hydraulic washing column, said ...
|
|
WO/2022/255369A1 |
The present invention provides a method for obtaining a product in a stable manner. The present invention is a heat exchanger for handling a solution containing an easily polymerizable compound or a slurry containing crystals of an easil...
|
|
WO/2022/255364A1 |
The present invention provides a method for efficiently obtaining a high-quality product. The present invention is a method for producing an easily polymerizable compound using a refining device having a crystallization tank for generati...
|
|
WO/2022/253907A1 |
The invention provides a pharmaceutically acceptable salt of 5-[[5-[4-(4-fluoro-1-methyl-4-piperidyl)-2-methoxy-phenyl]-1
H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile which is selected from maleate, tosylate, besylate and malonate salts....
|
|
WO/2022/255366A1 |
The present invention provides a method for obtaining high-quality products. The present invention relates to a tank used in a refining device, characterized in that: the tank is a crystallization tank for generating a slurry that contai...
|
|
WO/2022/250030A1 |
This method uses a heat exchange reactor, which is internally provided with a reaction tube, and produces (meth)acrolein and/or (meth)acrylic acid by means of an oxidation reaction of raw materials supplied to the reaction tube while cir...
|
|
WO/2022/251169A1 |
Crystalline salts of psilocin are disclosed. The beneficial and therapeutic uses of the crystalline psilocin salts and of compositions containing the crystalline psilocin salts are also disclosed. The disclosure sets out methods of makin...
|
|
WO/2022/246572A1 |
The present application relates to combination compositions comprising one or more hallucinogens, or a pharmaceutically acceptable salt, prodrug and/or solvate thereof, and one or more fatty acids, or a pharmaceutically acceptable salt, ...
|
